Flavaglines Stimulate Transient Receptor Potential Melastatin Type 6 (TRPM6) Channel Activity-Reference-Cited by-同舟云学术

Flavaglines Stimulate Transient Receptor Potential Melastatin Type 6 (TRPM6) Channel Activity

Published:2015-03-16 Issue:3 Volume:10 Page:e0119028
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Blanchard Maxime G.,de Baaij Jeroen H. F.,Verkaart Sjoerd A. J.,Lameris Anke L.,Basmadjian Christine,Zhao Qian,Désaubry Laurent,Bindels René J. M.,Hoenderop Joost G. J.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference36 articles.

1. Elucidation of the distal convoluted tubule transcriptome identifies new candidate genes involved in renal Mg(2+) handling;JH de Baaij;Am J Physiol Renal Physiol,2013

2. Regulation of magnesium balance: lessons learned from human genetic disease;JHF de Baaij;Clinical kidney journal,2012

3. TRPM6 forms the Mg2+ influx channel involved in intestinal and renal Mg2+ absorption;T Voets;J Biol Chem,2004

4. Mutation of TRPM6 causes familial hypomagnesemia with secondary hypocalcemia;RY Walder;Nat Genet,2002

5. Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family;KP Schlingmann;Nat Genet,2002

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Magnesium reabsorption in the kidney;American Journal of Physiology-Renal Physiology;2023-03-01

2. Insulin receptor substrate 4 deficiency mediates the insulin effect on the epithelial magnesium channel TRPM6 and causes hypomagnesemia;2022-10-04

3. SFPH proteins as therapeutic targets for a myriad of diseases;Bioorganic & Medicinal Chemistry Letters;2020-11

4. The identification of the high risk of metabolic syndrome by applying MDR and Jalview bioinformatics programs;Pharmacy & Pharmacology International Journal;2020-06-01

5. Growth suppression of human oral cancer cells by candidate agents for cetuximab-side effects;Experimental Cell Research;2019-03